Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2495
Diffuse Alveolar Hemorrhage in Patient with ANCA-associated Vasculitis AndInterstitial Lung Disease
Vasculitis – ANCA-Associated Poster III- 10:30AM-12:30PM
-
Abstract Number: 2157
Dimensionality of Inflammatory Back Pain Criteria in the US Population
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2155
Direct Comparison of Sleep Quality and Risk Factors for Poor Sleep Across Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2340
Direct to Patient Screening for Psoriatic Arthritis in Patients with Psoriasis: Diagnosis Rates, Referral Pathways, and Educational Value of Screening
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2135
Disability, Functional Limitation, and Use of Anti-fracture Drug Therapies in a Cohort of 3651 U.S. Adults with Osteogenesis Imperfecta
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2112
Discontinuation and Non-Publication of Osteoporosis Studies: An Observational Analysis of 7,670,624 Patients
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2113
Discontinuation and Non-publication of Postmenopausal Osteoporosis Clinical Studies: A Cross-sectional Analysis of 345,435 Patients
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2279
Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis Initiating Biologics or Targeted Synthetic DMARDs in Routine Care
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1986
Disease Flare Following Immune Checkpoint Inhibition in Patients with Cancer and Preexisting Vasculitis
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2450
Disease Progression in Anti-Centromere Positive Systemic Sclerosis Patients
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 1820
Disruption of Ca2+ Homeostasis and Enhanced Ca2+ Signaling in Scleroderma Fibroblasts Is Due to the Vicious Cycle Formed by Mitochondrial-derived Reactive Oxygen Species, CaMKII, and ER Extrusion Pump RYR2
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2136
Distal Radius Correlation with Femur and Lumbar Spine T-scores: A Comprehensive Analysis
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 1856
Distinct Proliferative and Special Properties of Peripheral Helper T Cells in RA Synovium
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 1818
Distribution and Morphological Changes of Adventitial Fibroblasts in Healthy and Scleroderma Skin